Package 54092-471-01

{"route": ["ORAL"], "spl_id": "11aa5df2-5a81-4786-8e21-20d00e6f4fbf", "openfda": {"unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["1927610", "1927616", "1927617", "1927619", "1927630", "1927632", "1927637", "1927639"], "spl_set_id": ["141a7970-3f06-44ea-9ab7-aeece2c085fc"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-471-01)", "package_ndc": "54092-471-01", "marketing_start_date": "20170620"}], "brand_name": "MYDAYIS", "product_id": "54092-471_11aa5df2-5a81-4786-8e21-20d00e6f4fbf", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "54092-471", "dea_schedule": "CII", "generic_name": "DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MYDAYIS", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "6.25 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "6.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "6.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "6.25 mg/1"}], "application_number": "NDA022063", "marketing_category": "NDA", "marketing_start_date": "20170620", "listing_expiration_date": "20261231"}